Recursos del Paciente

  1. Inicio
  2. Recursos del Paciente
  3. Resultados de su búsqueda

Manténgase sano!

Resultados de su búsqueda "Drug Approvals".

Resultados de noticias de salud - 13

17 Jul
Experimental Alzheimer's Drug Slows Thinking Declines in Late-Stage Trial

Experimental Alzheimer's Drug Slows Thinking Declines in Late-Stage Trial

Another experimental drug meant to slow the damage of Alzheimer's appears poised to join a growing arsenal of new treatments for this memory-robbing disease.

In research published online Monday in the

Alzheimer'sDrug ApprovalsClinical TrialsFood &, Drug Administration
06 Jul
FDA Gives Full Approval to Alzheimer's Drug Leqembi

FDA Gives Full Approval to Alzheimer's Drug Leqembi

The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer's drug Leqembi, clearing the way for insurance coverage of the pricey drug.

"The full FDA approval will open the floodgates for people with early Alzheimer's to get this drug. It's a bi...

Alzheimer'sHeart / Stroke-Related: Misc.Clinical TrialsDementiaNeurologyDrug ApprovalsFood &, Drug Administration
21 Jun
FDA Approves New Drugs to Treat Type 2 Diabetes in Kids

FDA Approves New Drugs to Treat Type 2 Diabetes in Kids

The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up.

The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provid...

Kids: Misc.Diabetes: Type IIDrug ApprovalsFood &, Drug Administration
19 May
FDA Approves First Pill to Treat Moderate-to-Severe Crohn's Disease

FDA Approves First Pill to Treat Moderate-to-Severe Crohn's Disease

Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).

Rinvoq is meant to treat adults with moderately to severely active Crohn's disease who have not had success with TNF (t...

Prescription DrugsCrohn's DiseaseDrug ApprovalsBowel Problems: Inflammatory Bowel DiseaseFood &, Drug Administration
11 May
FDA Approves First Drug Meant to Ease Alzheimer's-Linked Agitation

FDA Approves First Drug Meant to Ease Alzheimer's-Linked Agitation

A medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.

The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti ...

Alzheimer'sDementiaDrug ApprovalsFood &, Drug Administration
03 May
Experimental Alzheimer's Drug Slows Decline in Thinking in Late-Stage Trial

Experimental Alzheimer's Drug Slows Decline in Thinking in Late-Stage Trial

Another experimental drug meant for Alzheimer's disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June.

Known as donanemab, the medication clears amyloid plaque from the brain. In a lat...

Alzheimer'sDrug ApprovalsFood &, Drug Administration
09 Feb
Could a Vibrating Pill Ease Chronic Constipation?

Could a Vibrating Pill Ease Chronic Constipation?

A new treatment for chronic constipation may bring relief without having to use drugs.

It's a vibrating pill called Vibrant that stimulates the colon as it passes through the body.

Although the pill was

Irregularity / ConstipationDrug ApprovalsFood &, Drug Administration
12 Jan
FDA Approves New 2-Drug Combo Medicine for Asthma

FDA Approves New 2-Drug Combo Medicine for Asthma

Adults with asthma now have a new rescue medication to turn to after the U.S. Food and Drug Administration approved Airsupra on Wednesday.

The drug is the f...

Drug ApprovalsFood &, Drug AdministrationAsthma
01 Dec
First FDA-Approved Fecal-Based Treatment Helps Fight a Tough Superbug

First FDA-Approved Fecal-Based Treatment Helps Fight a Tough Superbug

The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections.

"Today's approval of Rebyota is an advance in caring f...

Drug ApprovalsInfections: Misc.Food &, Drug Administration
23 Nov
A Gene Therapy for Hemophilia That Costs $3.5 Million Gets FDA Approval

A Gene Therapy for Hemophilia That Costs $3.5 Million Gets FDA Approval

People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag.

The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov. 22. Soon after, drugmaker CSL Behring revealed its cost.

Health Care Access / DisparitiesGene TherapyHemophiliaDrug ApprovalsFood &, Drug Administration
30 Sep
FDA Approves New ALS Drug Despite Uncertain Data

FDA Approves New ALS Drug Despite Uncertain Data

The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for

NeurologyALS (Lou Gehrig's Disease)Drug ApprovalsFood &, Drug AdministrationBrain
23 Sep
Hints That Experimental Drug Might Curb a Form of ALS

Hints That Experimental Drug Might Curb a Form of ALS

People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows.

The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leads to

Genetic DisordersNeurologyALS (Lou Gehrig's Disease)Drug Approvals
29 Nov
Merck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDA

Merck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDA

Merck's experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administration.

On Friday morning Merck announced

Drug ApprovalsFood &, Drug Administration